These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6630761)

  • 21. Antiarrhythmic drugs and torsade de pointes.
    Lazzara R
    Eur Heart J; 1993 Nov; 14 Suppl H():88-92. PubMed ID: 8293758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epicardial activation patterns of torsade de pointes in canine hearts with quinidine-induced long QT interval but without myocardial infarction.
    Inoue H; Murakawa Y; Toda I; Nozaki A; Matsuo H; Mashima S; Sugimoto T
    Am Heart J; 1986 Jun; 111(6):1080-7. PubMed ID: 3716981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT prolongation and torsade de pointes ventricular tachycardia produced by Ketanserin.
    Aldariz AE; Romero H; Baroni M; Baglivo H; Esper RJ
    Pacing Clin Electrophysiol; 1986 Nov; 9(6):836-41. PubMed ID: 2432486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
    Keren A; Tzivoni D; Gavish D; Levi J; Gottlieb S; Benhorin J; Stern S
    Circulation; 1981 Dec; 64(6):1167-74. PubMed ID: 7296791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Torsade de pointes].
    Haverkamp W; Hördt M; Chen X; Hindricks G; Willems S; Kottkamp H; Rotman B; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Dec; 82(12):763-74. PubMed ID: 8147050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report.
    Katapadi K; Kostandy G; Katapadi M; Hussain KM; Schifter D
    Angiology; 1997 Sep; 48(9):821-6. PubMed ID: 9313632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance.
    Faigel DO; Metz DC; Kochman ML
    Am J Gastroenterol; 1995 May; 90(5):822-4. PubMed ID: 7733096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent?
    Viskin S; Fish R; Zeltser D; Belhassen B; Heller K; Brosh D; Laniado S; Barron HV
    Heart; 2000 Jun; 83(6):661-6. PubMed ID: 10814624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Torsade de pointes.
    Agarwal SK
    J Natl Med Assoc; 1981 Oct; 73(10):993-5. PubMed ID: 7310914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prinzmetal's angina with Torsade de Pointes ventricular tachycardia.
    Sawaya JI; Rubeiz GA
    Acta Cardiol; 1980; 35(1):47-54. PubMed ID: 6967668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Torsade de pointes and T-U wave alternans associated with arsenic poisoning.
    Little RE; Kay GN; Cavender JB; Epstein AE; Plumb VJ
    Pacing Clin Electrophysiol; 1990 Feb; 13(2):164-70. PubMed ID: 1689832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?
    Medina-Ravell VA; Lankipalli RS; Yan GX; Antzelevitch C; Medina-Malpica NA; Medina-Malpica OA; Droogan C; Kowey PR
    Circulation; 2003 Feb; 107(5):740-6. PubMed ID: 12578878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
    Ophoff N; Toker Y
    Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Torsade de pointes. A cause of syncope with atrioventricular block.
    Steinbrecher UP; Fitchett DH
    Arch Intern Med; 1980 Sep; 140(9):1223-6. PubMed ID: 7406620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Torsade de pointe. Report of 18 cases.
    Chalak W; Taha A; Araoya M; Rifaat M
    J Med Liban; 1993; 41(2):62-8; discussion 68-9. PubMed ID: 8057345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings.
    Locati EH; Maison-Blanche P; Dejode P; Cauchemez B; Coumel P
    J Am Coll Cardiol; 1995 Jun; 25(7):1564-75. PubMed ID: 7539014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.